Steven D. Nathan – författare
2 366 kr
Kommande
2 366 kr
Kommande
6 682 kr
Läs direkt efter köp
6 682 kr
Läs direkt efter köp
3 826 kr
Skickas inom 10-15 vardagar
2 840 kr
Läs direkt efter köp
1 446 kr
Skickas inom 10-15 vardagar
2 457 kr
Skickas inom 10-15 vardagar
2 840 kr
Läs direkt efter köp
1 722 kr
Läs direkt efter köp
787 kr
Skickas inom 10-15 vardagar
944 kr
Läs direkt efter köp
1 233 kr
Skickas inom 10-15 vardagar
1 101 kr
Läs direkt efter köp
The first edition of this book, published in 2009, was the only book of its kind dedicated exclusively to the diagnosis and management of pulmonary arterial hypertension (PAH) in patients with interstitial lung disease (ILD). Over the past few years, new diagnostic tests and treatments of pulmonary arterial hypertension have been developed and tested. Diagnostic testing has led to more frequent and specific diagnosis in PAH patients, leading to the more widespread use of effective treatment and improved quality of life and reduction of mortality for PAH patients. Pulmonary Hypertension and Interstitial Lung Disease: A Clinical Guide, Second Edition provides an updated and expanded state-of-the-art overview of the problems seen by physicians in the clinical management of ILDs. The first section of the book discusses general features and includes an overview of clinical features, diagnosis and pathology of ILD. The second part discusses specific disorders such as idiopathic pulmonary fibrosis, sarcoidosis, and hypersensitivity pneumonia. Pulmonary Hypertension and Interstitial Lung Disease, Second Edition is an invaluable resource for all physicians whose practice involves the care and treatment of patients with interstitial lung disease.
1 010 kr
Skickas inom 10-15 vardagar
1 901 kr
Skickas inom 10-15 vardagar
2 372 kr
Läs direkt efter köp
This book is a comprehensive guide to our current understanding of idiopathic pulmonary fibrosis (IPF), its disease pathogenesis, genetic underpinnings, diagnosis, and management. Since the first edition, many new developments have occurred in the understanding and management of this serious disease, revising our understanding of how it presents, manifests, and reacts to certain treatments. This second edition is fully updated with six new chapters by our team of international, expert authors. New topics include: classification of interstitial lung disease, pulmonary function tests in IPF, biomarkers, clinical phenotypes, mimics, and a discussion of clinical trials. Each chapter additionally includes a brief summary of ongoing research and potential future directions. Idiopathic Pulmonary Fibrosis: A Comprehensive Clinical Guide, Second Edition is an invaluable resource for clinicians who desire a deeper understanding of IPF in order to better help their patients.